AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
OSTEOSARCOMA OF THE EXTREMITIES WITH SYNCHRONOUS LUNG METASTASES - LONG-TERM RESULTS IN 44 PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY
Authors: BACCI G BRICCOLI A MERCURI M FERRARI S BERTONI F GASBARRINI A FABBRI N CESARI M FORNI C CAMPANACCI M
Citation: G. Bacci et al., OSTEOSARCOMA OF THE EXTREMITIES WITH SYNCHRONOUS LUNG METASTASES - LONG-TERM RESULTS IN 44 PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY, Journal of chemotherapy, 10(1), 1998, pp. 69-76
PEDIATRIC OSTEOSARCOMA - LONG-TERM RESULTS OF NEOADJUVANT TREATMENT
Authors: DELPREVER AB BESENZON L PINESCHI A MARINONI R BACCI G PICCI P
Citation: Ab. Delprever et al., PEDIATRIC OSTEOSARCOMA - LONG-TERM RESULTS OF NEOADJUVANT TREATMENT, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 353-366
NEOADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITY IN PATIENTS IN THE 4TH AND 5TH DECADE OF LIFE
Authors: BACCI G FERRARI S DONATI D LONGHI A BERTONI F DIFIORE M COMANDONE A CESARI M CAMPANACCI M
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITY IN PATIENTS IN THE 4TH AND 5TH DECADE OF LIFE, Oncology Reports, 5(5), 1998, pp. 1259-1263
NONMETASTATIC EWINGS-SARCOMA - PRELIMINARY-RESULTS OF A PROTOCOL WITHIFOSFAMIDE SINCE THE INDUCTION-PHASE ADDED TO VINCRISTINE, DOXORUBICIN, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE AND ETOPOSIDE
Authors: FERRARI S BACCI G MERCURI M BERTONI F PICCI P BARBIERI E ROSITO P DELPREVER AB TIENGHI A COMANDONE A
Citation: S. Ferrari et al., NONMETASTATIC EWINGS-SARCOMA - PRELIMINARY-RESULTS OF A PROTOCOL WITHIFOSFAMIDE SINCE THE INDUCTION-PHASE ADDED TO VINCRISTINE, DOXORUBICIN, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE AND ETOPOSIDE, Annals of oncology, 9, 1998, pp. 554-554
MONITORING METHOTREXATE LEVELS IN OSTEOSARCOMA - IN REPLY
Authors: BACCI G
Citation: G. Bacci, MONITORING METHOTREXATE LEVELS IN OSTEOSARCOMA - IN REPLY, Journal of clinical oncology, 16(6), 1998, pp. 2291-2291
PREDICTIVE FACTORS OF HISTOLOGIC RESPONSE TO PRIMARY CHEMOTHERAPY IN OSTEOSARCOMA OF THE EXTREMITY - STUDY OF 272 PATIENTS PREOPERATIVELY TREATED WITH HIGH-DOSE METHOTREXATE, DOXORUBICIN, AND CISPLATIN
Authors: BACCI G FERRARI S DELEPINE N BERTONI F PICCI P MERCURI M BACCHINI P DELPREVER AB TIENGHI A COMANDONE A CAMPANACCI M
Citation: G. Bacci et al., PREDICTIVE FACTORS OF HISTOLOGIC RESPONSE TO PRIMARY CHEMOTHERAPY IN OSTEOSARCOMA OF THE EXTREMITY - STUDY OF 272 PATIENTS PREOPERATIVELY TREATED WITH HIGH-DOSE METHOTREXATE, DOXORUBICIN, AND CISPLATIN, Journal of clinical oncology, 16(2), 1998, pp. 658-663
NON CONVENTIONAL FRACTIONATION IN RADIOTHERAPY OF THE MUSCULOSKELETALSARCOMAS
Authors: BARBIERI E FREZZA G MARTELLI O NERI S MERCURI M GHERLINZONI F BACCI G MANCINI A PUTTI C BABINI L
Citation: E. Barbieri et al., NON CONVENTIONAL FRACTIONATION IN RADIOTHERAPY OF THE MUSCULOSKELETALSARCOMAS, Tumori, 84(2), 1998, pp. 167-170
FOLLOW-UP PROTOCOLS IN ORTHOPEDIC ONCOLOGY
Authors: DONATI D BINI SA BACCI G CAMPANACCI M
Citation: D. Donati et al., FOLLOW-UP PROTOCOLS IN ORTHOPEDIC ONCOLOGY, Tumori, 84(1), 1998, pp. 57-59
NEOADJUVANT CHEMOTHERAPY FOR EXTREMITY OSTEOSARCOMA - PRELIMINARY-RESULTS OF THE RIZZOLIS 4TH STUDY
Authors: BACCI G FERRARI S MERCURI M LONGHI A CAPANNA R TIENGHI A DELPREVER AB COMANDONE A CESARI M BERNINI G PICCI P
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR EXTREMITY OSTEOSARCOMA - PRELIMINARY-RESULTS OF THE RIZZOLIS 4TH STUDY, Acta oncologica, 37(1), 1998, pp. 41-48
NEOADJUVANT CHEMOTHERAPY FOR HIGH-GRADE MALIGNANT FIBROUS HISTIOCYTOMA OF BONE
Authors: BACCI G PICCI P MERCURI M BERTONI F FERRARI S
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR HIGH-GRADE MALIGNANT FIBROUS HISTIOCYTOMA OF BONE, Clinical orthopaedics and related research, (346), 1998, pp. 178-189
NEOADJUVANT CHEMOTHERAPY FOR EWINGS-SARCOMA OF BONE - NO BENEFIT OBSERVED AFTER ADDING IFOSFAMIDE AND ETOPOSIDE TO VINCRISTINE, ACTINOMYCIN, CYCLOPHOSPHAMIDE, AND DOXORUBICIN IN THE MAINTENANCE PHASE - RESULTSOF 2 SEQUENTIAL STUDIES
Authors: BACCI G PICCI P FERRARI S MERCURI M DELPREVER AB ROSITO P BARBIERI E TIENGHI A FORNI C
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR EWINGS-SARCOMA OF BONE - NO BENEFIT OBSERVED AFTER ADDING IFOSFAMIDE AND ETOPOSIDE TO VINCRISTINE, ACTINOMYCIN, CYCLOPHOSPHAMIDE, AND DOXORUBICIN IN THE MAINTENANCE PHASE - RESULTSOF 2 SEQUENTIAL STUDIES, Cancer, 82(6), 1998, pp. 1174-1183
PREDICTIVE FACTORS FOR LOCAL RECURRENCE IN OSTEOSARCOMA - 540 PATIENTS WITH EXTREMITY TUMORS FOLLOWED FOR MINIMUM 2.5 YEARS AFTER NEOADJUVANT CHEMOTHERAPY
Authors: BACCI G FERRARI S MERCURI M BERTONI F PICCI P MANFRINI M GASBARRINI A FORNI C CESARI M CAMPANACCI M
Citation: G. Bacci et al., PREDICTIVE FACTORS FOR LOCAL RECURRENCE IN OSTEOSARCOMA - 540 PATIENTS WITH EXTREMITY TUMORS FOLLOWED FOR MINIMUM 2.5 YEARS AFTER NEOADJUVANT CHEMOTHERAPY, Acta orthopaedica Scandinavica, 69(3), 1998, pp. 230-236
NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN
Authors: BACCI G FERRARI S BERTONI F MERCURI M FORNI C SOTTILI S GASBARRINI A TIENGHI A CESARI M CAMPANACCI M
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN, Journal of chemotherapy, 9(4), 1997, pp. 293-299
LONG-TERM FOLLOW-UP FOR PATIENTS WITH EWINGS-SARCOMA OF BONE TREATED WITH ADJUVANT AND NEOADJUVANT CHEMOTHERAPY - UPDATED RESULTS OF 3 SEQUENTIAL STUDIES
Authors: BACCI G FERRARI S BARBIERI E LONGHI A FORNI C CESARI M SARTI M GASBARRINI A ROSITO P DELPREVER AB
Citation: G. Bacci et al., LONG-TERM FOLLOW-UP FOR PATIENTS WITH EWINGS-SARCOMA OF BONE TREATED WITH ADJUVANT AND NEOADJUVANT CHEMOTHERAPY - UPDATED RESULTS OF 3 SEQUENTIAL STUDIES, Oncology Reports, 4(5), 1997, pp. 977-985
HIGH-DOSE METHOTREXATE (HDMTX) PHARMACOKINETIC PROFILE IN OSTEOSARCOMA PATIENTS
Authors: COMANDONE A BOGLIONE A BACCI G OLIVA C BERGNOLO P LEONE L FERRARI S BUMMA C
Citation: A. Comandone et al., HIGH-DOSE METHOTREXATE (HDMTX) PHARMACOKINETIC PROFILE IN OSTEOSARCOMA PATIENTS, European journal of cancer, 33, 1997, pp. 1128-1128
COMPARISON OF 2 TYPES OF CENTRAL VENOUS CATHETER (CVC) IN A POPULATION OF PATIENTS WITH BONE SARCOMA
Authors: LORO L BEGHELLI C TREMOSINI M SIMONI P SPEDICATO L FERRARI S BACCI G
Citation: L. Loro et al., COMPARISON OF 2 TYPES OF CENTRAL VENOUS CATHETER (CVC) IN A POPULATION OF PATIENTS WITH BONE SARCOMA, European journal of cancer, 33, 1997, pp. 1459-1459
LONG-TERM FOLLOW-UP AND POST-RELAPSE SURVIVAL IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITY TREATED WITH NEOADJUVANT CHEMOTHERAPY
Authors: FERRARI S BACCI G PICCI P MERCURI M BRICCOLI A PINTO D GASBARRINI A TIENGHI A DELPREVER AB
Citation: S. Ferrari et al., LONG-TERM FOLLOW-UP AND POST-RELAPSE SURVIVAL IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITY TREATED WITH NEOADJUVANT CHEMOTHERAPY, Annals of oncology, 8(8), 1997, pp. 765-771
NEOADJUVANT CHEMOTHERAPY IN MALIGNANT FIBROUS HISTIOCYTOMA OF BONE AND IN OSTEOSARCOMA LOCATED IN THE EXTREMITIES - ANALOGIES AND DIFFERENCES BETWEEN THE 2 TUMORS
Authors: PICCI P BACCI G FERRARI S MERCURI M
Citation: P. Picci et al., NEOADJUVANT CHEMOTHERAPY IN MALIGNANT FIBROUS HISTIOCYTOMA OF BONE AND IN OSTEOSARCOMA LOCATED IN THE EXTREMITIES - ANALOGIES AND DIFFERENCES BETWEEN THE 2 TUMORS, Annals of oncology, 8(11), 1997, pp. 1107-1115
CHEMOTHERAPY-INDUCED TUMOR NECROSIS AS A PROGNOSTIC FACTOR IN LOCALIZED EWINGS-SARCOMA OF THE EXTREMITIES
Authors: PICCI P BOHLING T BACCI G FERRARI S SANGIORGI L MERCURI M RUGGIERI P MANFRINI M FERRARO A CASADEI R BENASSI MS MANCINI AF ROSITO P CAZZOLA A BARBIERI E TIENGHI A DELPREVER AB COMANDONE A BACCHINI P BERTONI F
Citation: P. Picci et al., CHEMOTHERAPY-INDUCED TUMOR NECROSIS AS A PROGNOSTIC FACTOR IN LOCALIZED EWINGS-SARCOMA OF THE EXTREMITIES, Journal of clinical oncology, 15(4), 1997, pp. 1553-1559
INTENSITY ON OUTCOME OF PATIENTS WITH HIGH-GRADE OSTEOGENIC OSTEOSARCOMA - ANALYSIS OF THE LITERATURE - REPLY
Authors: DELEPINE N DELEPINE G BACCI G ROSEN G DESBOIS JC
Citation: N. Delepine et al., INTENSITY ON OUTCOME OF PATIENTS WITH HIGH-GRADE OSTEOGENIC OSTEOSARCOMA - ANALYSIS OF THE LITERATURE - REPLY, Cancer, 80(3), 1997, pp. 517-518
OSTEOGENIC-SARCOMA OF THE EXTREMITY WITH DETECTABLE LUNG METASTASES AT PRESENTATION - RESULTS OF TREATMENT OF 23 PATIENTS WITH CHEMOTHERAPYFOLLOWED BY SIMULTANEOUS RESECTION OF PRIMARY AND METASTATIC LESIONS
Authors: BACCI G MERCURI M BRICCOLI A FERRARI S BERTONI F DONATI D MONTI C ZANONI A FORNI C MANFRINI M
Citation: G. Bacci et al., OSTEOGENIC-SARCOMA OF THE EXTREMITY WITH DETECTABLE LUNG METASTASES AT PRESENTATION - RESULTS OF TREATMENT OF 23 PATIENTS WITH CHEMOTHERAPYFOLLOWED BY SIMULTANEOUS RESECTION OF PRIMARY AND METASTATIC LESIONS, Cancer, 79(2), 1997, pp. 245-254
METHOTREXATE SERUM CONCENTRATION AND HISTOLOGICAL RESPONSE TO MULTIAGENT PRIMARY CHEMOTHERAPY FOR OSTEOSARCOMA OF THE LIMBS
Authors: BACCI G FERRARI S PICCI P ZOLEZZI C GHERLINZONI F IANTORNO D CAZZOLA A
Citation: G. Bacci et al., METHOTREXATE SERUM CONCENTRATION AND HISTOLOGICAL RESPONSE TO MULTIAGENT PRIMARY CHEMOTHERAPY FOR OSTEOSARCOMA OF THE LIMBS, Journal of chemotherapy, 8(6), 1996, pp. 472-478
THE ROLE OF CORRECTED QT INTERVAL IN THE CARDIOLOGIC FOLLOW-UP OF YOUNG-PATIENTS TREATED WITH ADRIAMYCIN
Authors: FERRARI S FIGUS E CAGNANO R IANTORNO D BACCI G
Citation: S. Ferrari et al., THE ROLE OF CORRECTED QT INTERVAL IN THE CARDIOLOGIC FOLLOW-UP OF YOUNG-PATIENTS TREATED WITH ADRIAMYCIN, Journal of chemotherapy, 8(3), 1996, pp. 232-236
INTRAARTERIAL VERSUS INTRAVENOUS CISPLATINUM (IN ADDITION TO SYSTEMICADRIAMYCIN AND HIGH-DOSE METHOTREXATE) IN THE NEOADJUVANT TREATMENT OF OSTEOSARCOMA OF THE EXTREMITIES - RESULTS OF A RANDOMIZED STUDY
Authors: BACCI G RUGGIERI P PICCI P MERCURI M FERRARO A TELLA G FERRARI S BERTONI F COMANDONE A
Citation: G. Bacci et al., INTRAARTERIAL VERSUS INTRAVENOUS CISPLATINUM (IN ADDITION TO SYSTEMICADRIAMYCIN AND HIGH-DOSE METHOTREXATE) IN THE NEOADJUVANT TREATMENT OF OSTEOSARCOMA OF THE EXTREMITIES - RESULTS OF A RANDOMIZED STUDY, Journal of chemotherapy, 8(1), 1996, pp. 70-81
SYNCHRONOUS MULTIFOCAL OSTEOSARCOMA - RESULTS IN 12 PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND SIMULTANEOUS RESECTION OF ALL INVOLVED BONES
Authors: BACCI G PICCI P FERRARI S MERCURI M BRICCOLI A DONATI D MANFRINI M ZANONI A FORNI C CAMPANACCI M
Citation: G. Bacci et al., SYNCHRONOUS MULTIFOCAL OSTEOSARCOMA - RESULTS IN 12 PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND SIMULTANEOUS RESECTION OF ALL INVOLVED BONES, Annals of oncology, 7(8), 1996, pp. 864-866
Risultati: 1-25 | 26-41